[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339370-105":59,"doc-detail-339370-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","an-improved-epigenetic-counter-to-track-mitotic-age-in-normal-and-precancerous-tissues-research-and-validation-study","An improved epigenetic counter to track mitotic age in normal and precancerous tissues - Research and validation study","","A mitotic age measurement, defined as cumulative stem cell divisions that influence cancer risk, is explored through DNA methylation (DNAm) clocks. The study constructs and validates stemTOC, an improved pan-tissue DNAm counter of total mitotic age. stemTOC’s mitotic age proxy increases with tumor cell-of-origin fraction across 15 cancer types, in precancerous lesions, and in normal tissues exposed to cancer risk factors. Benchmarking against six mitotic counters shows favorable performance, especially in preinvasive and normal contexts.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/an-improved-epigenetic-counter-to-track-mitotic-age-in-normal-and-precancerous-tissues-research-and-validation-study/339370/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/an-improved-epigenetic-counter-to-track-mitotic-age-in-normal-and-precancerous-tissues-research-and-validation-study/339370.png","ImageObject",300,407,{"name":92,"@type":93},"Eliana","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is mitotic age and why is it important for cancer risk?","Question",{"text":113,"@type":114},"Mitotic age represents the cumulative number of stem cell divisions in a tissue. It is linked to cancer risk because molecular alterations accumulate after stem-cell division and can predispose cell subclones to transformation.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What is stemTOC and what does it measure?",{"text":118,"@type":114},"stemTOC is an improved pan-tissue DNAm counter designed to estimate total mitotic age. It aims to reduce confounding effects and account for stochastic DNAm patterns.",{"name":120,"@type":111,"acceptedAnswer":121},"How does stemTOC perform compared with other mitotic counters?",{"text":122,"@type":114},"Extensive benchmarking against six other mitotic counters shows that stemTOC compares favorably, particularly in preinvasive and normal-tissue contexts.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},339370,1790872043,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","Article [https://doi.org/10.1038/s41467-024-48649-8](https://doi.org/10.1038/s41467-024-48649-8)  \nAn improved epigenetic counter to track mitotic age in normal and precancerous tissues  \nReceived: 24 September 2023  \n\n| Accepted: 9 May 2024 |\n| --- |\n| |\n| Check for updates |\n\nTianyu Zhu1,3, Huige Tong 1,3, Zhaozhen Du1, Stephan Beck 2 & Andrew E. Teschendorff 1   \nThe cumulative number of stem cell divisions in a tissue, known as mitotic age, is thought to be a major determinant of cancer-risk. Somatic mutational and DNA methylation (DNAm) clocks are promising tools to molecularly track mitotic age, yet their relationship is underexplored and their potential for cancer risk prediction in normal tissues remains to be demonstrated. Here we build and validate an improved pan-tissue DNAm counter of total mitotic age called stemTOC. We demonstrate that stemTOC’s mitotic age proxy increases with the tumor cell-of-origin fraction in each of 15 cancer-types, in precancerous lesions, and in normal tissues exposed to major cancer risk factors. Extensive benchmarking against 6 other mitotic counters shows that stemTOC compares favorably, specially in the preinvasive and normal-tissue contexts. By cross-correlating stemTOC to two clock-like somatic mutational signatures, we conﬁrm the mitotic-like nature of only one of these. Our data points towards DNAm as a promising molecular substrate for detecting mitotic-age increases in normal tissues and precancerous lesions, and hence for developing cancer-risk prediction strategies.  \nA key priority area of precision and preventive oncology is to develop novel strategies for early detection and risk prediction1,2. Given the growing evidence that the risk of neoplastic transformation of any given tissue in any given individual is strongly inﬂuenced by the cumulative number of stem-cell divisions (aka mitotic age) that the underlying cell-of-origin has undergone2–5, the ability to measure this mitotic age in human tissues could help address this clinical need. Underpinning the association of mitotic age with cancer risk is the gradual accumulation of molecular alterations following stem-cell division, eventually predisposing speciﬁc subclones to neoplastic transformation6–12. Conversely, these molecular alterations, if measured, could be used to estimate mitotic age11,13–22.  \nAmong the potential molecular alterations that could be used to measure mitotic age, somatic mutations and DNA methylation(DNAm)  \nhave emerged as the most promising ones11,14,15,23. DNAm-based mitotic-like counters hypothesized to track the cumulative number of DNA methylation errors arising during cell division in both stem-cell and expanding progenitor cell populations have been proposed16–18,24–29, yet confounders such as cell-type heterogeneity (CTH)30 and chronological age24 have cast doubt on the biological and clinical signiﬁcance of these counters and their total mitotic age estimates (deﬁned here as the cumulative number of divisions in both stem-cells and amplifying progenitor populations). Moreover, DNAm changes in normal and preneoplastic lesions often display a stochastic pattern19,31,32, which can pose speciﬁc statistical challenges to estimating mitotic age. Finally, although the relation between clock-likeDNAm and somatic mutational signatures has already undergone preliminary investigations18,33, these studies have only explored this in the context  \n1CAS Key Laboratory of Computational Biology, CAS-MPG Partner Institute for Computational Biology, Shanghai Institute of Nutrition and Health, Shanghai Institute for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, 320 Yue Yang Road, Shanghai 200031, China. 2Medical Genomics Group, UCL Cancer Institute, University College London, 72 Huntley Street, WC1E 6BT London, UK. 3These authors contributed equally:  \nTianyu Zhu, Huige Tong. e-mail: [andrew@sinh.ac.cn](andrew@sinh.ac.cn)  \nof B cell malignancies33 or did not di","cbCait04AwsPK6TG","https://ap.wps.com/l/cbCait04AwsPK6TG","pdf",2439457,"English","# Abstract\n# Results\n## Construction of stemTOC\n## Benchmarking against other mitotic counters\n## Linking stemTOC to mutational signatures\n## Implications for cancer-risk prediction","[{\"question\":\"What is mitotic age and why is it important for cancer risk?\",\"answer\":\"Mitotic age represents the cumulative number of stem cell divisions in a tissue. It is linked to cancer risk because molecular alterations accumulate after stem-cell division and can predispose cell subclones to transformation.\"},{\"question\":\"What is stemTOC and what does it measure?\",\"answer\":\"stemTOC is an improved pan-tissue DNAm counter designed to estimate total mitotic age. It aims to reduce confounding effects and account for stochastic DNAm patterns.\"},{\"question\":\"How does stemTOC perform compared with other mitotic counters?\",\"answer\":\"Extensive benchmarking against six other mitotic counters shows that stemTOC compares favorably, particularly in preinvasive and normal-tissue contexts.\"}]","An improved epigenetic counter to track mitotic age in normal and precancerous tissues - Research and validation study | PDF",1790029849,48,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/10a4d1a4fa0d058b2521b3ee04a4891d.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ddad3aed7d4d33fd3653ba93498d2fd.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/87f599e7915475d97bed28c0f28b3580.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c23893f8f7a105675ed54e5c3dfabd1a.webp",980,1301]